# Everlab

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/everlab

- Industry: Healthcare IT
- Headquarters: Melbourne, Australia
- Website: www.everlab.au/
- Total disclosed funding: $56M
- Latest round: Series A (Jun 16, 2026)
- Investors on record: 5

## About

Based in Australia, Everlab Pty Ltd operates as a consumer-focused preventative healthcare platform provider. The company provides diagnostic testing, clinician-led healthcare services, and AI-enabled health management tools that help individuals monitor and improve long-term health outcomes.|

Based in Melbourne, Australia and founded in 2023, Everlab Pty Ltd provides preventative healthcare, diagnostics, and digital health management solutions for the healthcare industry. The company was founded by Marc Hermann, Sam Kothari, Anshul Jain, and Dr. Steven Lu to improve healthcare through continuous monitoring and early risk detection. Everlab combines diagnostics, clinician-led care, wearable integration, and AI-powered insights within a unified platform. Since launch, the company has expanded across Australia and New Zealand while serving individual and corporate clients. As of June 2026, the company is led by its CEO, Marc Hermann. In June 2026, Everlab raised AUD 65 million in series A funding led by AirTree Ventures, with participation from Plural, b2venture, and Left Lane Capital.

The company works with consumers and enterprises to provide preventative healthcare, diagnostics, and longitudinal health management solutions. Everlab’s platform integrates diagnostics, specialist referrals, doctors, prescriptions, wearable-device data, and continuous AI-supported care into a single digital experience. The company offers biomarker testing, health assessments, personalized health plans, medical record organization, and preventive care programs designed to identify health risks before symptoms emerge. Engineers, clinicians, healthcare specialists, and technology professionals support the platform’s development and operation. Its services are used by individual members as well as organizations including Boston Consulting Group, BHP, and Bain & Company.

The company’s revenue is generated by providing preventative healthcare programs, diagnostic testing services, health assessments, and membership-based care offerings to consumers. Everlab offers healthcare packages that include biomarker testing, personalized healthcare planning, access to clinicians, and ongoing health monitoring. The company also serves enterprise clients through workplace health programs and preventative care solutions. Revenue is further supported through integrated healthcare services, specialist coordination, and digital platform access that helps members manage their health information and care journeys.

The company will use the June 2026 funding to strengthen its clinical and technology infrastructure and accelerate its global expansion.

## Funding rounds

- Series A, Jun 16, 2026, $46M — b2venture, AirTree Ventures, Left Lane Capital, Plural
- Seed, Jul 21, 2025, $9.9M — b2venture, Left Lane Capital, Afterwork Ventures

## Investors

- b2venture (https://capitalatlas.ai/funds/b2venture) — Seed, Series A
- Left Lane Capital (https://capitalatlas.ai/funds/left-lane-capital) — Seed, Series A
- Afterwork Ventures (https://capitalatlas.ai/funds/afterwork-ventures) — Seed
- AirTree Ventures (https://capitalatlas.ai/funds/airtree-ventures) — Series A
- Plural (https://capitalatlas.ai/funds/plural) — Series A